Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Rivaroxaban group
DRUG
2 trials
Sponsors
Assistance Publique - Hôpitaux de Paris
, hedi chaker hospital
Conditions
Circulatory System
Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA)
Phase 1
RIVARAD study
Active, not recruiting
PACTR202110633346282
hedi chaker hospital
Circulatory System
Start: 2021-11-01
Target: 512
Updated: 2026-08-03
Phase 4
Rivaroxaban Versus Standard of Care for Patients With Excessive Atrial Ectopy or Short Atrial Runs and High Embolism Risk
Not yet recruiting
NCT05487950
Assistance Publique - Hôpitaux de Paris
Excessive Supraventricular Ectopies or Short Atrial Runs (ESVEA)
Start: 2023-04-05
End: 2027-04-05
Target: 550
Updated: 2023-03-28